1308 Artificial intelligence (AI)-powered immune phenotyping based on programmed death ligand 1 (PD-L1) immunohistochemistry (IHC) in triple negative breast cancer (TNBC)

• Chan-Young Ock,
• Seulki Kim,
• Siraj Ali,
• Soo Ick Cho,
• Gahee Park,
• Seunghwan Shin,
• Jeongun Ryu,
• Seonwook Park,
• Sangwon Shin,
• Taebum Lee,
• Juneyoung Ro,
• Aaron Valero,
• Biagio Brattoli,
• Changho Ahn

Affiliations

Chan-Young Ock

Lunit Inc., Seoul, Republic of Korea

Seulki Kim

Lunit Inc., Seoul, Republic of Korea

Siraj Ali

Lunit Inc., Seoul, Republic of Korea

Soo Ick Cho

Lunit Inc., Seoul, Republic of Korea

Gahee Park

Lunit Inc., Seoul, Republic of Korea

Seunghwan Shin

Lunit Inc., Seoul, Republic of Korea

Jeongun Ryu

Lunit Inc., Seoul, Republic of Korea

Seonwook Park

Lunit Inc., Seoul, Republic of Korea

Sangwon Shin

Lunit Inc., Seoul, Republic of Korea

Taebum Lee

Lunit Inc., Seoul, Republic of Korea

Juneyoung Ro

Lunit Inc., Seoul, Republic of Korea

Aaron Valero

Lunit Inc., Seoul, Republic of Korea

Biagio Brattoli

Lunit Inc., Seoul, Republic of Korea

Changho Ahn

Lunit Inc., Seoul, Republic of Korea